Phototoxic	O
action	O
of	O
a	O
zinc	B:C0078832
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
encapsulated	O
into	O
poloxamine	O
polymeric	O
micelles	I:C0025938
in	O
2D	O
and	O
3D	O
colon	O
carcinoma	I:C0699790
cell	O
cultures	I:C0007585
Photodynamic	O
therapy	I:C0031740
is	O
emerging	O
as	O
a	O
hopeful	O
method	O
for	O
the	O
treatment	O
of	O
oncological	O
diseases	I:C0012634
.	O

Phototoxic	O
action	O
of	O
a	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
encapsulated	O
into	O
poloxamine	B:C1876683
polymeric	O
micelles	I:C0025938
in	O
2D	O
and	O
3D	O
colon	O
carcinoma	I:C0699790
cell	O
cultures	I:C0007585
Photodynamic	O
therapy	I:C0031740
is	O
emerging	O
as	O
a	O
hopeful	O
method	O
for	O
the	O
treatment	O
of	O
oncological	O
diseases	I:C0012634
.	O

Phototoxic	O
action	O
of	O
a	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
encapsulated	O
into	O
poloxamine	O
polymeric	B:C0025938
micelles	I:C0025938
in	O
2D	O
and	O
3D	O
colon	O
carcinoma	I:C0699790
cell	O
cultures	I:C0007585
Photodynamic	O
therapy	I:C0031740
is	O
emerging	O
as	O
a	O
hopeful	O
method	O
for	O
the	O
treatment	O
of	O
oncological	O
diseases	I:C0012634
.	O

Phototoxic	O
action	O
of	O
a	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
encapsulated	O
into	O
poloxamine	O
polymeric	O
micelles	I:C0025938
in	O
2D	B:C1705052
and	O
3D	O
colon	O
carcinoma	I:C0699790
cell	O
cultures	I:C0007585
Photodynamic	O
therapy	I:C0031740
is	O
emerging	O
as	O
a	O
hopeful	O
method	O
for	O
the	O
treatment	O
of	O
oncological	O
diseases	I:C0012634
.	O

Phototoxic	O
action	O
of	O
a	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
encapsulated	O
into	O
poloxamine	O
polymeric	O
micelles	I:C0025938
in	O
2D	O
and	O
3D	B:C0450363
colon	O
carcinoma	I:C0699790
cell	O
cultures	I:C0007585
Photodynamic	O
therapy	I:C0031740
is	O
emerging	O
as	O
a	O
hopeful	O
method	O
for	O
the	O
treatment	O
of	O
oncological	O
diseases	I:C0012634
.	O

Phototoxic	O
action	O
of	O
a	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
encapsulated	O
into	O
poloxamine	O
polymeric	O
micelles	I:C0025938
in	O
2D	O
and	O
3D	O
colon	B:C0699790
carcinoma	I:C0699790
cell	O
cultures	I:C0007585
Photodynamic	O
therapy	I:C0031740
is	O
emerging	O
as	O
a	O
hopeful	O
method	O
for	O
the	O
treatment	O
of	O
oncological	O
diseases	I:C0012634
.	O

Phototoxic	O
action	O
of	O
a	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
encapsulated	O
into	O
poloxamine	O
polymeric	O
micelles	I:C0025938
in	O
2D	O
and	O
3D	O
colon	O
carcinoma	I:C0699790
cell	B:C0007585
cultures	I:C0007585
Photodynamic	O
therapy	I:C0031740
is	O
emerging	O
as	O
a	O
hopeful	O
method	O
for	O
the	O
treatment	O
of	O
oncological	O
diseases	I:C0012634
.	O

Phototoxic	O
action	O
of	O
a	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
encapsulated	O
into	O
poloxamine	O
polymeric	O
micelles	I:C0025938
in	O
2D	O
and	O
3D	O
colon	O
carcinoma	I:C0699790
cell	O
cultures	I:C0007585
Photodynamic	B:C0031740
therapy	I:C0031740
is	O
emerging	O
as	O
a	O
hopeful	O
method	O
for	O
the	O
treatment	O
of	O
oncological	O
diseases	I:C0012634
.	O

Phototoxic	O
action	O
of	O
a	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
encapsulated	O
into	O
poloxamine	O
polymeric	O
micelles	I:C0025938
in	O
2D	O
and	O
3D	O
colon	O
carcinoma	I:C0699790
cell	O
cultures	I:C0007585
Photodynamic	O
therapy	I:C0031740
is	O
emerging	O
as	O
a	O
hopeful	O
method	O
for	O
the	O
treatment	B:C0087111
of	O
oncological	O
diseases	I:C0012634
.	O

Phototoxic	O
action	O
of	O
a	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
encapsulated	O
into	O
poloxamine	O
polymeric	O
micelles	I:C0025938
in	O
2D	O
and	O
3D	O
colon	O
carcinoma	I:C0699790
cell	O
cultures	I:C0007585
Photodynamic	O
therapy	I:C0031740
is	O
emerging	O
as	O
a	O
hopeful	O
method	O
for	O
the	O
treatment	O
of	O
oncological	B:C0012634
diseases	I:C0012634
.	O

In	O
the	O
search	O
of	O
novel	O
therapeutic	O
strategies	O
for	O
colorectal	B:C1527249
cancer	I:C1527249
,	O
in	O
this	O
work	O
we	O
reported	O
the	O
photocytotoxic	O
activity	O
of	O
a	O
lipophilic	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
on	O
a	O
murine	O
colon	O
adenocarcinoma	I:C0338106
cell	O
line	I:C0007600
(	O
CT26	O
cells	I:C0007634
)	O
.	O

In	O
the	O
search	O
of	O
novel	O
therapeutic	O
strategies	O
for	O
colorectal	O
cancer	I:C1527249
,	O
in	O
this	O
work	O
we	O
reported	O
the	O
photocytotoxic	O
activity	O
of	O
a	O
lipophilic	O
zinc	B:C0078832
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
on	O
a	O
murine	O
colon	O
adenocarcinoma	I:C0338106
cell	O
line	I:C0007600
(	O
CT26	O
cells	I:C0007634
)	O
.	O

In	O
the	O
search	O
of	O
novel	O
therapeutic	O
strategies	O
for	O
colorectal	O
cancer	I:C1527249
,	O
in	O
this	O
work	O
we	O
reported	O
the	O
photocytotoxic	O
activity	O
of	O
a	O
lipophilic	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
on	O
a	O
murine	B:C0026809
colon	O
adenocarcinoma	I:C0338106
cell	O
line	I:C0007600
(	O
CT26	O
cells	I:C0007634
)	O
.	O

In	O
the	O
search	O
of	O
novel	O
therapeutic	O
strategies	O
for	O
colorectal	O
cancer	I:C1527249
,	O
in	O
this	O
work	O
we	O
reported	O
the	O
photocytotoxic	O
activity	O
of	O
a	O
lipophilic	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
on	O
a	O
murine	O
colon	B:C0338106
adenocarcinoma	I:C0338106
cell	O
line	I:C0007600
(	O
CT26	O
cells	I:C0007634
)	O
.	O

In	O
the	O
search	O
of	O
novel	O
therapeutic	O
strategies	O
for	O
colorectal	O
cancer	I:C1527249
,	O
in	O
this	O
work	O
we	O
reported	O
the	O
photocytotoxic	O
activity	O
of	O
a	O
lipophilic	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
on	O
a	O
murine	O
colon	O
adenocarcinoma	I:C0338106
cell	B:C0007600
line	I:C0007600
(	O
CT26	O
cells	I:C0007634
)	O
.	O

In	O
the	O
search	O
of	O
novel	O
therapeutic	O
strategies	O
for	O
colorectal	O
cancer	I:C1527249
,	O
in	O
this	O
work	O
we	O
reported	O
the	O
photocytotoxic	O
activity	O
of	O
a	O
lipophilic	O
zinc	O
(	I:C0078832
II	I:C0078832
)	I:C0078832
phthalocyanine	I:C0078832
on	O
a	O
murine	O
colon	O
adenocarcinoma	I:C0338106
cell	O
line	I:C0007600
(	O
CT26	B:C0007634
cells	I:C0007634
)	O
.	O

The	O
2,9	B:C1254351
(	I:C1254351
10	I:C1254351
)	I:C1254351
,16	I:C1254351
(	I:C1254351
17	I:C1254351
)	I:C1254351
,23	I:C1254351
(	I:C1254351
24	I:C1254351
)	I:C1254351
tetrakis	I:C1254351
[	I:C1254351
(	I:C1254351
2-	I:C1254351
dimethylamino)ethylsulfanyl]phthalocyaninatozinc(	I:C1254351
II	I:C1254351
)	I:C1254351
,	O
named	O
Pc9	O
,	O
was	O
encapsulated	O
into	O
Tetronic	O
®	I:C0675004
1107	I:C0675004
polymeric	O
poloxamine	I:C1876683
micelles	I:C1876683
(	O
T1107	O
)	O
and	O
assayed	O
in	O
2D	O
and	O
3D	O
cell	O
cultures	I:C0007585
.	O

The	O
2,9	O
(	I:C1254351
10	I:C1254351
)	I:C1254351
,16	I:C1254351
(	I:C1254351
17	I:C1254351
)	I:C1254351
,23	I:C1254351
(	I:C1254351
24	I:C1254351
)	I:C1254351
tetrakis	I:C1254351
[	I:C1254351
(	I:C1254351
2-	I:C1254351
dimethylamino)ethylsulfanyl]phthalocyaninatozinc(	I:C1254351
II	I:C1254351
)	I:C1254351
,	O
named	O
Pc9	B:C1254351
,	O
was	O
encapsulated	O
into	O
Tetronic	O
®	I:C0675004
1107	I:C0675004
polymeric	O
poloxamine	I:C1876683
micelles	I:C1876683
(	O
T1107	O
)	O
and	O
assayed	O
in	O
2D	O
and	O
3D	O
cell	O
cultures	I:C0007585
.	O

The	O
2,9	O
(	I:C1254351
10	I:C1254351
)	I:C1254351
,16	I:C1254351
(	I:C1254351
17	I:C1254351
)	I:C1254351
,23	I:C1254351
(	I:C1254351
24	I:C1254351
)	I:C1254351
tetrakis	I:C1254351
[	I:C1254351
(	I:C1254351
2-	I:C1254351
dimethylamino)ethylsulfanyl]phthalocyaninatozinc(	I:C1254351
II	I:C1254351
)	I:C1254351
,	O
named	O
Pc9	O
,	O
was	O
encapsulated	O
into	O
Tetronic	B:C0675004
®	I:C0675004
1107	I:C0675004
polymeric	O
poloxamine	I:C1876683
micelles	I:C1876683
(	O
T1107	O
)	O
and	O
assayed	O
in	O
2D	O
and	O
3D	O
cell	O
cultures	I:C0007585
.	O

The	O
2,9	O
(	I:C1254351
10	I:C1254351
)	I:C1254351
,16	I:C1254351
(	I:C1254351
17	I:C1254351
)	I:C1254351
,23	I:C1254351
(	I:C1254351
24	I:C1254351
)	I:C1254351
tetrakis	I:C1254351
[	I:C1254351
(	I:C1254351
2-	I:C1254351
dimethylamino)ethylsulfanyl]phthalocyaninatozinc(	I:C1254351
II	I:C1254351
)	I:C1254351
,	O
named	O
Pc9	O
,	O
was	O
encapsulated	O
into	O
Tetronic	O
®	I:C0675004
1107	I:C0675004
polymeric	B:C1876683
poloxamine	I:C1876683
micelles	I:C1876683
(	O
T1107	O
)	O
and	O
assayed	O
in	O
2D	O
and	O
3D	O
cell	O
cultures	I:C0007585
.	O

The	O
2,9	O
(	I:C1254351
10	I:C1254351
)	I:C1254351
,16	I:C1254351
(	I:C1254351
17	I:C1254351
)	I:C1254351
,23	I:C1254351
(	I:C1254351
24	I:C1254351
)	I:C1254351
tetrakis	I:C1254351
[	I:C1254351
(	I:C1254351
2-	I:C1254351
dimethylamino)ethylsulfanyl]phthalocyaninatozinc(	I:C1254351
II	I:C1254351
)	I:C1254351
,	O
named	O
Pc9	O
,	O
was	O
encapsulated	O
into	O
Tetronic	O
®	I:C0675004
1107	I:C0675004
polymeric	O
poloxamine	I:C1876683
micelles	I:C1876683
(	O
T1107	B:C0675004
)	O
and	O
assayed	O
in	O
2D	O
and	O
3D	O
cell	O
cultures	I:C0007585
.	O

The	O
2,9	O
(	I:C1254351
10	I:C1254351
)	I:C1254351
,16	I:C1254351
(	I:C1254351
17	I:C1254351
)	I:C1254351
,23	I:C1254351
(	I:C1254351
24	I:C1254351
)	I:C1254351
tetrakis	I:C1254351
[	I:C1254351
(	I:C1254351
2-	I:C1254351
dimethylamino)ethylsulfanyl]phthalocyaninatozinc(	I:C1254351
II	I:C1254351
)	I:C1254351
,	O
named	O
Pc9	O
,	O
was	O
encapsulated	O
into	O
Tetronic	O
®	I:C0675004
1107	I:C0675004
polymeric	O
poloxamine	I:C1876683
micelles	I:C1876683
(	O
T1107	O
)	O
and	O
assayed	O
in	O
2D	B:C1705052
and	O
3D	O
cell	O
cultures	I:C0007585
.	O

The	O
2,9	O
(	I:C1254351
10	I:C1254351
)	I:C1254351
,16	I:C1254351
(	I:C1254351
17	I:C1254351
)	I:C1254351
,23	I:C1254351
(	I:C1254351
24	I:C1254351
)	I:C1254351
tetrakis	I:C1254351
[	I:C1254351
(	I:C1254351
2-	I:C1254351
dimethylamino)ethylsulfanyl]phthalocyaninatozinc(	I:C1254351
II	I:C1254351
)	I:C1254351
,	O
named	O
Pc9	O
,	O
was	O
encapsulated	O
into	O
Tetronic	O
®	I:C0675004
1107	I:C0675004
polymeric	O
poloxamine	I:C1876683
micelles	I:C1876683
(	O
T1107	O
)	O
and	O
assayed	O
in	O
2D	O
and	O
3D	B:C0450363
cell	O
cultures	I:C0007585
.	O

The	O
2,9	O
(	I:C1254351
10	I:C1254351
)	I:C1254351
,16	I:C1254351
(	I:C1254351
17	I:C1254351
)	I:C1254351
,23	I:C1254351
(	I:C1254351
24	I:C1254351
)	I:C1254351
tetrakis	I:C1254351
[	I:C1254351
(	I:C1254351
2-	I:C1254351
dimethylamino)ethylsulfanyl]phthalocyaninatozinc(	I:C1254351
II	I:C1254351
)	I:C1254351
,	O
named	O
Pc9	O
,	O
was	O
encapsulated	O
into	O
Tetronic	O
®	I:C0675004
1107	I:C0675004
polymeric	O
poloxamine	I:C1876683
micelles	I:C1876683
(	O
T1107	O
)	O
and	O
assayed	O
in	O
2D	O
and	O
3D	O
cell	B:C0007585
cultures	I:C0007585
.	O

We	O
showed	O
that	O
the	O
formulation	O
Pc9	B:C1254351
-	O
T1107	O
was	O
efficient	O
to	O
reduce	O
cell	O
viability	I:C0007620
after	O
photodynamic	O
treatment	I:C0031740
both	O
in	O
2D	O
cultures	O
(	O
IC50	O
10±2nM	O
)	O
as	O
well	O
as	O
in	O
CT26	O
spheroids	I:C0282501
(	O
IC50	O
370±11nM	O
)	O
.	O

We	O
showed	O
that	O
the	O
formulation	O
Pc9	O
-	O
T1107	B:C0675004
was	O
efficient	O
to	O
reduce	O
cell	O
viability	I:C0007620
after	O
photodynamic	O
treatment	I:C0031740
both	O
in	O
2D	O
cultures	O
(	O
IC50	O
10±2nM	O
)	O
as	O
well	O
as	O
in	O
CT26	O
spheroids	I:C0282501
(	O
IC50	O
370±11nM	O
)	O
.	O

We	O
showed	O
that	O
the	O
formulation	O
Pc9	O
-	O
T1107	O
was	O
efficient	O
to	O
reduce	O
cell	B:C0007620
viability	I:C0007620
after	O
photodynamic	O
treatment	I:C0031740
both	O
in	O
2D	O
cultures	O
(	O
IC50	O
10±2nM	O
)	O
as	O
well	O
as	O
in	O
CT26	O
spheroids	I:C0282501
(	O
IC50	O
370±11nM	O
)	O
.	O

We	O
showed	O
that	O
the	O
formulation	O
Pc9	O
-	O
T1107	O
was	O
efficient	O
to	O
reduce	O
cell	O
viability	I:C0007620
after	O
photodynamic	B:C0031740
treatment	I:C0031740
both	O
in	O
2D	O
cultures	O
(	O
IC50	O
10±2nM	O
)	O
as	O
well	O
as	O
in	O
CT26	O
spheroids	I:C0282501
(	O
IC50	O
370±11nM	O
)	O
.	O

We	O
showed	O
that	O
the	O
formulation	O
Pc9	O
-	O
T1107	O
was	O
efficient	O
to	O
reduce	O
cell	O
viability	I:C0007620
after	O
photodynamic	O
treatment	I:C0031740
both	O
in	O
2D	B:C1705052
cultures	O
(	O
IC50	O
10±2nM	O
)	O
as	O
well	O
as	O
in	O
CT26	O
spheroids	I:C0282501
(	O
IC50	O
370±11nM	O
)	O
.	O

We	O
showed	O
that	O
the	O
formulation	O
Pc9	O
-	O
T1107	O
was	O
efficient	O
to	O
reduce	O
cell	O
viability	I:C0007620
after	O
photodynamic	O
treatment	I:C0031740
both	O
in	O
2D	O
cultures	B:C0007585
(	O
IC50	O
10±2nM	O
)	O
as	O
well	O
as	O
in	O
CT26	O
spheroids	I:C0282501
(	O
IC50	O
370±11nM	O
)	O
.	O

We	O
showed	O
that	O
the	O
formulation	O
Pc9	O
-	O
T1107	O
was	O
efficient	O
to	O
reduce	O
cell	O
viability	I:C0007620
after	O
photodynamic	O
treatment	I:C0031740
both	O
in	O
2D	O
cultures	O
(	O
IC50	O
10±2nM	O
)	O
as	O
well	O
as	O
in	O
CT26	B:C0282501
spheroids	I:C0282501
(	O
IC50	O
370±11nM	O
)	O
.	O

Cellular	B:C0007613
uptake	I:C0007613
of	O
Pc9	O
-	O
T1107	O
was	O
a	O
time	O
-	O
and	O
concentration	O
-	O
dependent	O
process	O
,	O
being	O
the	O
phthalocyanine	O
formulation	O
mainly	O
incorporated	O
into	O
lysosomal	O
vesicles	O
and	O
endoplasmic	O
reticulum	I:C1166837
cisterns	I:C1166837
,	O
but	O
not	O
in	O
mitochondria	O
.	O

Cellular	O
uptake	I:C0007613
of	O
Pc9	B:C1254351
-	O
T1107	O
was	O
a	O
time	O
-	O
and	O
concentration	O
-	O
dependent	O
process	O
,	O
being	O
the	O
phthalocyanine	O
formulation	O
mainly	O
incorporated	O
into	O
lysosomal	O
vesicles	O
and	O
endoplasmic	O
reticulum	I:C1166837
cisterns	I:C1166837
,	O
but	O
not	O
in	O
mitochondria	O
.	O

Cellular	O
uptake	I:C0007613
of	O
Pc9	O
-	O
T1107	B:C0675004
was	O
a	O
time	O
-	O
and	O
concentration	O
-	O
dependent	O
process	O
,	O
being	O
the	O
phthalocyanine	O
formulation	O
mainly	O
incorporated	O
into	O
lysosomal	O
vesicles	O
and	O
endoplasmic	O
reticulum	I:C1166837
cisterns	I:C1166837
,	O
but	O
not	O
in	O
mitochondria	O
.	O

Cellular	O
uptake	I:C0007613
of	O
Pc9	O
-	O
T1107	O
was	O
a	O
time	O
-	O
and	O
concentration	O
-	O
dependent	O
process	O
,	O
being	O
the	O
phthalocyanine	B:C0078832
formulation	O
mainly	O
incorporated	O
into	O
lysosomal	O
vesicles	O
and	O
endoplasmic	O
reticulum	I:C1166837
cisterns	I:C1166837
,	O
but	O
not	O
in	O
mitochondria	O
.	O

Cellular	O
uptake	I:C0007613
of	O
Pc9	O
-	O
T1107	O
was	O
a	O
time	O
-	O
and	O
concentration	O
-	O
dependent	O
process	O
,	O
being	O
the	O
phthalocyanine	O
formulation	O
mainly	O
incorporated	O
into	O
lysosomal	O
vesicles	B:C1622418
and	O
endoplasmic	O
reticulum	I:C1166837
cisterns	I:C1166837
,	O
but	O
not	O
in	O
mitochondria	O
.	O

Cellular	O
uptake	I:C0007613
of	O
Pc9	O
-	O
T1107	O
was	O
a	O
time	O
-	O
and	O
concentration	O
-	O
dependent	O
process	O
,	O
being	O
the	O
phthalocyanine	O
formulation	O
mainly	O
incorporated	O
into	O
lysosomal	O
vesicles	O
and	O
endoplasmic	B:C1166837
reticulum	I:C1166837
cisterns	I:C1166837
,	O
but	O
not	O
in	O
mitochondria	O
.	O

Cellular	O
uptake	I:C0007613
of	O
Pc9	O
-	O
T1107	O
was	O
a	O
time	O
-	O
and	O
concentration	O
-	O
dependent	O
process	O
,	O
being	O
the	O
phthalocyanine	O
formulation	O
mainly	O
incorporated	O
into	O
lysosomal	O
vesicles	O
and	O
endoplasmic	O
reticulum	I:C1166837
cisterns	I:C1166837
,	O
but	O
not	O
in	O
mitochondria	B:C0026237
.	O

Pc9	B:C1254351
-	O
T1107	O
also	O
induced	O
the	O
formation	O
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
immediately	O
after	O
cell	O
irradiation	O
.	O

Pc9	O
-	O
T1107	B:C0675004
also	O
induced	O
the	O
formation	O
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
immediately	O
after	O
cell	O
irradiation	O
.	O

Pc9	O
-	O
T1107	O
also	O
induced	O
the	O
formation	O
of	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
immediately	O
after	O
cell	O
irradiation	O
.	O

Pc9	O
-	O
T1107	O
also	O
induced	O
the	O
formation	O
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
immediately	O
after	O
cell	B:C0007634
irradiation	O
.	O

We	O
also	O
found	O
that	O
the	O
phototoxic	O
action	O
of	O
Pc9	B:C1254351
-	O
T1107	O
was	O
partially	O
reversed	O
in	O
the	O
presence	O
of	O
antioxidants	O
,	O
such	O
as	O
TROLOX	O
and	O
N	O
-	I:C0001047
acetyl	I:C0001047
-	I:C0001047
cysteine	I:C0001047
.	O

We	O
also	O
found	O
that	O
the	O
phototoxic	O
action	O
of	O
Pc9	O
-	O
T1107	B:C0675004
was	O
partially	O
reversed	O
in	O
the	O
presence	O
of	O
antioxidants	O
,	O
such	O
as	O
TROLOX	O
and	O
N	O
-	I:C0001047
acetyl	I:C0001047
-	I:C0001047
cysteine	I:C0001047
.	O

We	O
also	O
found	O
that	O
the	O
phototoxic	O
action	O
of	O
Pc9	O
-	O
T1107	O
was	O
partially	O
reversed	O
in	O
the	O
presence	O
of	O
antioxidants	B:C0003402
,	O
such	O
as	O
TROLOX	O
and	O
N	O
-	I:C0001047
acetyl	I:C0001047
-	I:C0001047
cysteine	I:C0001047
.	O

We	O
also	O
found	O
that	O
the	O
phototoxic	O
action	O
of	O
Pc9	O
-	O
T1107	O
was	O
partially	O
reversed	O
in	O
the	O
presence	O
of	O
antioxidants	O
,	O
such	O
as	O
TROLOX	B:C0147003
and	O
N	O
-	I:C0001047
acetyl	I:C0001047
-	I:C0001047
cysteine	I:C0001047
.	O

We	O
also	O
found	O
that	O
the	O
phototoxic	O
action	O
of	O
Pc9	O
-	O
T1107	O
was	O
partially	O
reversed	O
in	O
the	O
presence	O
of	O
antioxidants	O
,	O
such	O
as	O
TROLOX	O
and	O
N	B:C0001047
-	I:C0001047
acetyl	I:C0001047
-	I:C0001047
cysteine	I:C0001047
.	O

In	O
addition	O
,	O
we	O
showed	O
that	O
Pc9	B:C1254351
-	O
T1107	O
treatment	O
triggered	O
an	O
apoptotic	O
cell	I:C0162638
death	I:C0162638
,	I:C0162638
as	O
suggested	O
by	O
the	O
detection	O
of	O
pyknotic	O
nuclei	O
,	O
the	O
reduction	O
in	O
the	O
expression	O
levels	O
of	O
procaspase	O
-	I:C0758915
3	I:C0758915
and	O
the	O
increase	O
in	O
caspase	O
-	I:C0291573
3	I:C0291573
enzymatic	O
activity	I:C2267219
.	O

In	O
addition	O
,	O
we	O
showed	O
that	O
Pc9	O
-	O
T1107	B:C0675004
treatment	O
triggered	O
an	O
apoptotic	O
cell	I:C0162638
death	I:C0162638
,	I:C0162638
as	O
suggested	O
by	O
the	O
detection	O
of	O
pyknotic	O
nuclei	O
,	O
the	O
reduction	O
in	O
the	O
expression	O
levels	O
of	O
procaspase	O
-	I:C0758915
3	I:C0758915
and	O
the	O
increase	O
in	O
caspase	O
-	I:C0291573
3	I:C0291573
enzymatic	O
activity	I:C2267219
.	O

In	O
addition	O
,	O
we	O
showed	O
that	O
Pc9	O
-	O
T1107	O
treatment	B:C0087111
triggered	O
an	O
apoptotic	O
cell	I:C0162638
death	I:C0162638
,	I:C0162638
as	O
suggested	O
by	O
the	O
detection	O
of	O
pyknotic	O
nuclei	O
,	O
the	O
reduction	O
in	O
the	O
expression	O
levels	O
of	O
procaspase	O
-	I:C0758915
3	I:C0758915
and	O
the	O
increase	O
in	O
caspase	O
-	I:C0291573
3	I:C0291573
enzymatic	O
activity	I:C2267219
.	O

In	O
addition	O
,	O
we	O
showed	O
that	O
Pc9	O
-	O
T1107	O
treatment	O
triggered	O
an	O
apoptotic	B:C0162638
cell	I:C0162638
death	I:C0162638
,	I:C0162638
as	O
suggested	O
by	O
the	O
detection	O
of	O
pyknotic	O
nuclei	O
,	O
the	O
reduction	O
in	O
the	O
expression	O
levels	O
of	O
procaspase	O
-	I:C0758915
3	I:C0758915
and	O
the	O
increase	O
in	O
caspase	O
-	I:C0291573
3	I:C0291573
enzymatic	O
activity	I:C2267219
.	O

In	O
addition	O
,	O
we	O
showed	O
that	O
Pc9	O
-	O
T1107	O
treatment	O
triggered	O
an	O
apoptotic	O
cell	I:C0162638
death	I:C0162638
,	I:C0162638
as	O
suggested	O
by	O
the	O
detection	B:C0442726
of	O
pyknotic	O
nuclei	O
,	O
the	O
reduction	O
in	O
the	O
expression	O
levels	O
of	O
procaspase	O
-	I:C0758915
3	I:C0758915
and	O
the	O
increase	O
in	O
caspase	O
-	I:C0291573
3	I:C0291573
enzymatic	O
activity	I:C2267219
.	O

In	O
addition	O
,	O
we	O
showed	O
that	O
Pc9	O
-	O
T1107	O
treatment	O
triggered	O
an	O
apoptotic	O
cell	I:C0162638
death	I:C0162638
,	I:C0162638
as	O
suggested	O
by	O
the	O
detection	O
of	O
pyknotic	B:C0333904
nuclei	O
,	O
the	O
reduction	O
in	O
the	O
expression	O
levels	O
of	O
procaspase	O
-	I:C0758915
3	I:C0758915
and	O
the	O
increase	O
in	O
caspase	O
-	I:C0291573
3	I:C0291573
enzymatic	O
activity	I:C2267219
.	O

In	O
addition	O
,	O
we	O
showed	O
that	O
Pc9	O
-	O
T1107	O
treatment	O
triggered	O
an	O
apoptotic	O
cell	I:C0162638
death	I:C0162638
,	I:C0162638
as	O
suggested	O
by	O
the	O
detection	O
of	O
pyknotic	O
nuclei	B:C0007610
,	O
the	O
reduction	O
in	O
the	O
expression	O
levels	O
of	O
procaspase	O
-	I:C0758915
3	I:C0758915
and	O
the	O
increase	O
in	O
caspase	O
-	I:C0291573
3	I:C0291573
enzymatic	O
activity	I:C2267219
.	O

In	O
addition	O
,	O
we	O
showed	O
that	O
Pc9	O
-	O
T1107	O
treatment	O
triggered	O
an	O
apoptotic	O
cell	I:C0162638
death	I:C0162638
,	I:C0162638
as	O
suggested	O
by	O
the	O
detection	O
of	O
pyknotic	O
nuclei	O
,	O
the	O
reduction	O
in	O
the	O
expression	B:C1171362
levels	O
of	O
procaspase	O
-	I:C0758915
3	I:C0758915
and	O
the	O
increase	O
in	O
caspase	O
-	I:C0291573
3	I:C0291573
enzymatic	O
activity	I:C2267219
.	O

In	O
addition	O
,	O
we	O
showed	O
that	O
Pc9	O
-	O
T1107	O
treatment	O
triggered	O
an	O
apoptotic	O
cell	I:C0162638
death	I:C0162638
,	I:C0162638
as	O
suggested	O
by	O
the	O
detection	O
of	O
pyknotic	O
nuclei	O
,	O
the	O
reduction	O
in	O
the	O
expression	O
levels	O
of	O
procaspase	B:C0758915
-	I:C0758915
3	I:C0758915
and	O
the	O
increase	O
in	O
caspase	O
-	I:C0291573
3	I:C0291573
enzymatic	O
activity	I:C2267219
.	O

In	O
addition	O
,	O
we	O
showed	O
that	O
Pc9	O
-	O
T1107	O
treatment	O
triggered	O
an	O
apoptotic	O
cell	I:C0162638
death	I:C0162638
,	I:C0162638
as	O
suggested	O
by	O
the	O
detection	O
of	O
pyknotic	O
nuclei	O
,	O
the	O
reduction	O
in	O
the	O
expression	O
levels	O
of	O
procaspase	O
-	I:C0758915
3	I:C0758915
and	O
the	O
increase	O
in	O
caspase	B:C0291573
-	I:C0291573
3	I:C0291573
enzymatic	O
activity	I:C2267219
.	O

In	O
addition	O
,	O
we	O
showed	O
that	O
Pc9	O
-	O
T1107	O
treatment	O
triggered	O
an	O
apoptotic	O
cell	I:C0162638
death	I:C0162638
,	I:C0162638
as	O
suggested	O
by	O
the	O
detection	O
of	O
pyknotic	O
nuclei	O
,	O
the	O
reduction	O
in	O
the	O
expression	O
levels	O
of	O
procaspase	O
-	I:C0758915
3	I:C0758915
and	O
the	O
increase	O
in	O
caspase	O
-	I:C0291573
3	I:C0291573
enzymatic	B:C2267219
activity	I:C2267219
.	O

